Nine Dragons Paper (Holdings) Limited (NDGPY) Fair Value & Analysis
Basic Materials · US · Market cap $3.9B
Fair value as of: Jun 24, 2026
Analysis
Nine Dragons Paper (Holdings) Limited (NDGPY) currently trades at $16.75, while our model-based Fair Value estimate is $22.27 — implying the stock looks roughly 33.0% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Nine Dragons Paper (Holdings) Limited, together with its subsidiaries, manufactures and sells packaging paper, printing and writing paper, and specialty paper products and pulp in the People's Republic of China. The company offers kraft, test, white top, and coated linerboard, as well as bleached folding boxboard; corrugating medium; uncoated wood free and office paper; coated duplex board; and gypsum board cover paper. It also provides container board, kraft paper, and packaging products; corrugated sheet, cardboard, and carton box; kraft paper bag; color printing; and laminated paper products. The company was founded in 1995 and is headquartered in Dongguan, the People's Republic of China. Nine Dragons Paper (Holdings) Limited is a subsidiary of Best Result Holdings Limited.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Nine Dragons Paper (Holdings) Limited (NDGPY) undervalued?
What is the fair value of NDGPY?
What is the quality score of NDGPY?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.